Skip to content

Author

A. Thakkinstian

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

In-hospital and 1-year mortality after percutaneous coronary intervention in patients without standard modifiable risk factors: a mediation analysis from Thai PCI registry

Standard modifiable risk factors (SMuRFs), including hypertension, hypercholesterolemia, diabetes, and smoking, contribute substantially to atherosclerosis. However, patients with SMuRF-less remain at risk of mortality after percutaneous coronary intervention (PCI). The mechanisms underlying this risk are not wel...

S. Kiatchoosakun, P. Chichareon, C. Wongwipaporn et al. · 0 citations
Open access Oct 2026

Real-world comparative effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation

Background and purpose Long-term oral anticoagulants (OACs), either vitamin K antagonists or direct oral anticoagulants (DOACs), are essential for stroke prevention in atrial fibrillation (AF). However, comparative real-world evidence among DOACs in upper-middle-income settings remains inconsistent. This study compared...

Sureerat Suwatcharangkoon, S. Rattanasiri, N. Unwanatham et al. · 0 citations
Open access Oct 2026

Incidence of diabetes remission and association with microvascular and macrovascular complications in patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study using real-world data in Thailand

Abstract Objective To estimate the incidence of diabetes remission and relapse among patients with type 2 diabetes (T2DM) and to assess the association between remission status and cardiorenal outcomes using a multistate analysis of long-term real-world data in Thailand. Design Retrospective cohort study using real-wor...

Atittaya Janram, Ornanong Chanajarunwit, T. Anothaisintawee et al. · 0 citations
Review Open access Sep 2026

Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A Tutorial.

Systematic reviews of economic evaluations are increasingly used to inform healthcare decision making, yet approaches for a cost-effectiveness meta-analysis vary substantially, and clear methodological guidance remains limited. Differences in country income level, currency, cost reference year, analytic perspective, ti...

R. Collet, J. V. van Dongen, O. Pattanaprateep et al. · 0 citations
Review Aug 2026

Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.

INTRODUCTION Extended cost-effectiveness analysis (ECEA) incorporates financial risk protection (FRP) and distributional outcomes across socioeconomic groups. This study assessed FRP outcomes and synthesized the landscape of ECEA applications. METHODS A systematic literature search was conducted in PubMed, Scopus, IN...

Sarayuth Khuntha, Sitaporn Youngkong, Ukrit Sitthiboot et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.